Description
Buy 2-FDCK Online | Secured Tracked Logistics EU
Order High-Purity 2-FDCK for Laboratory Research
Shipping : We prioritize fast shipping and secure packaging, so your order arrives quickly and confidentially. All orders are packaged in plain, unmarked boxes to ensure your privacy. Additionally, every shipment includes a surprise gift as a token of our appreciation for choosing us
Technical Specifications & Product Identification Data
-
- Systematic IUPAC Nomenclature: 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one
- Standard CAS Registry Number: 111982-50-4 (Base Form)
- Molecular Formula: C₁₃H₁₆FNO · HCl (Refined Hydrochloride Crystal Form)
- Exact Molar Mass: 221.27 g/mol (Base) | 257.73 g/mol (Refined HCl Salt variant)
- Physical Presentation: Translucent to off-white large crystal structures or dense powder
- Structural Classification: Arylcyclohexylamine derivative and fluorinated structural analogue of ketamine, featuring a fluorine substitution at the ortho position of the phenyl ring.
Theoretical Pharmacology & Documented Adverse Effects
Legal Status & European Regulations
-
- European Union: Closely monitored by the European Union Drugs Agency (EUDA) and blanket-banned across multiple EU Member States. National laws—such as Germany’s NpSG (broad structural group ban) and equivalent narcotic acts in France and the Netherlands—restrict distribution solely to state-authorized scientific installations holding specialized permits.
- United Kingdom: Strictly prohibited under the Psychoactive Substances Act 2016, criminalizing unauthorized production, supply, or importation into British territory.
Authorized Research Use & Safety Warning
Frequently Asked Questions (FAQ)
As a potent arylcyclohexylamine derivative, exposure to 2-FDCK carries substantial neurological and cardiovascular risks. Documented adverse reactions include severe cognitive dissociation, hypertensive strain, rapid heart rate (tachycardia), profound motor incoordination, and bladder wall toxicity. Prolonged exposure or high doses may lead to permanent cognitive deficits or organ strain.
The molecular structure of 2-FDCK differs from ketamine by a single halogen substitution on the phenyl ring. While standard ketamine incorporates a chlorine atom at the ortho position, 2-FDCK replaces this with a highly electronegative fluorine atom, noticeably altering its lipophilicity and molecular clearance behaviors.
No. In the majority of jurisdictions, including the United Kingdom and the European Union, 2-FDCK is heavily restricted or classified as a controlled substance. Unauthorized possession, supply, or importation is a criminal offense. Legal access is strictly limited to authorized scientific research institutions holding active government-issued permits.
